Xilio Therapeutics Reports Second Quarter 2026 Financial Results And Provides Pipeline And Business Updates
XLO•Second-quarter results and pipeline update
Aug. 12 (Reuters) - Xilio Therapeutics Inc XLO.O:
- Xilio Therapeutics reports second quarter 2026 financial results and provides pipeline and business updates
- Xilio Therapeutics plans to report initial Phase 1 data in patients with metastatic NSCLC in H2 2027
- Xilio Therapeutics expects cash runway into Q1 2028
Source text: ID:nGNX8ZCxXg
Further company coverage: XLO.O
